Jenny M. Reimer

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Ousmane Traoré et al. · The Lancet · 2021 · 431 citations · Full text

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Duncan Bellamy et al. · The Lancet Infectious Diseases · 2022 · 268 citations

Vaccination, Clinical Malaria, Burkina Faso +8

Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen

Jenny M. Reimer, Karin H. Karlsson, Karin Lövgren‐Bengtsson et al. · PLoS ONE · 2012 · 124 citations · Full text

Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice

Sofia Magnusson, Jenny M. Reimer, Karin H. Karlsson et al. · Vaccine · 2013 · 72 citations

Vaccination, Allergy, Immunology +9

Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution

Maike Gallwitz, Jenny M. Reimer, Lars Hellman · Immunogenetics · 2006 · 55 citations

Biology, Immunogenetics, Past 200 +7